It is a business services private limited company based in Pondicherry, Pondicherry, India, established in 2011.
2011 | Pondicherry, Pondicherry, India | Struck OffSapphire Pharmaceuticals Private Limited, a struck off private limited company, was established on 14 March 2011 in Pondicherry, Pondicherry, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74900PY2011PTC002562. Registered under ROC Roc Pondicherry. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.30 M.
Its leadership includes John Rex Paul (Director), Karupannan Murugesan (Director), Suseelan Sivakumar (Managing Director). Past directors included Surekha Williams, Chitra Ramalingam, Bamila Rex. Its latest AGM occurred on 28 September 2012, with the balance sheet filed on 31 March 2012. It is based at Rs No 2, Plot No 145 And 146 Vazhudavur Road, Kurumbapet, Pondicherry, Pondicherry, 605009.
U74900PY2011PTC002562
002562
14 March 2011
₹0.50 M
₹0.30 M
Roc Pondicherry
Unlisted
Struck Off
Explore comprehensive insights into Sapphire Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| John Rex Paul | Director | 27 May 2013 | Current |
| Karupannan Murugesan | Director | 27 May 2013 | Current |
| Suseelan Sivakumar | Managing Director | 27 May 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 05 Jun 2013 | Past |
| Pramod Abcsdd | Director | 05 Jun 2013 | Past |
| Pramod Abcsdd | Director | 27 May 2013 | Past |
| Pramod Abcsdd | Director | 05 Jun 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Sapphire Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Sapphire Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sapphire Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sapphire Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sapphire Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity John Rex Paul was appointed as a Director was appointed as a Director on 27 May 2013 & has been associated with this company since 12 years 7 months . was completed.
Progress on Karupannan Murugesan was appointed as a Director was appointed as a Director on 27 May 2013 & has been associated with this company since 12 years 7 months . was documented.
Progress on Suseelan Sivakumar was appointed as a Managing Director was appointed as a Managing Director on 27 May 2013 & has been associated with this company since 12 years 7 months . was documented.
Progress on Sapphire Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2012 as per latest MCA records. was documented.
Sapphire Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2012 with Roc Pondicherry. was recorded as a recent event.
Sapphire Pharmaceuticals Private Limited was registered on 14 Mar 2011 with Roc Pondicherry & aged 14 years 9 months as per MCA records. was recorded as a recent event.
The CIN of Sapphire Pharmaceuticals Private Limited is U74900PY2011PTC002562.
Sapphire Pharmaceuticals Private Limited is headquartered at Rs No 2, Plot No 145 And 146 Vazhudavur Road, Kurumbapet, Pondicherry, Pondicherry, 605009.
Sapphire Pharmaceuticals Private Limited was incorporated on 14 March 2011.
The current directors of Sapphire Pharmaceuticals Private Limited are
The primary industry of Sapphire Pharmaceuticals Private Limited is Business Services.
Sapphire Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sapphire Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.30 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX